Abstract:Background. The discovery of the presence of fetal genetic material in maternal blood has opened up a new approach to prenatal diagnosis. One approach that has been extensively investigated over the past few decades is the isolation of fetal cells from maternal blood (Herzenberg et al. Proc Natl Acad Sci USA. 1979;76:1453-5; Bianchi et al. Proc Natl Acad Sci USA. 1990;87:3279-83; Cha et al. Prenat Diagn. 2005-25:586-91). As the fetal cells are scarce and the enrichment is of low efficiency, the technique could not be implemented in clinics. In 1997, Lo et al. (Lancet 1997-350(9076):485-7) discovered that cell-free fetal DNA is present in the plasma and serum of pregnant women. This discovery suggests that maternal plasma/serum DNA may be a useful source of material for non-invasive prenatal diagnosis. The objective of our study was to investigate the feasibility of using fetal DNA in maternal plasma for prenatal diagnosis. Methods. Plasma DNA in 277 blood samples of 40 pregnant women at the gestational period from 5 to 40 weeks and 24 h after delivery were extracted by column separation. FQ-PCR was used to amplify the SRY sequence in 237 plasma samples of 30 pregnant women. Fluorescent PCR was used to amplify 9 short tandem repeat loci simultaneously in 40 plasma samples of 10 pregnant women, and genomic DNA samples from their husbands were amplified by the same method. Results. The fetal SRY sequence could be detected from the 7th week of gestation, with a concentration that increased with progressing gestational age, attaining its highest peak before delivery. Twenty-four hours after delivery, fetal SRY sequence could not be detected in the maternal plasma. The concordance rate of the SRY sequence amplification results of plasma-free DNA, with real fetal gender was 100%. Analysis of maternal plasma samples collected during pregnancy revealed the presence of paternally inherited fetal-specific alleles. Among the 30 collected plasma samples, fetal-specific alleles were detected in 23 plasma DNA samples. The rate of positive results was 76% (23/30), and the frequency of positive results was 6/10 in early pregnancy, 8/10 in middle pregnancy, and 9/10 in late pregnancy. Short tandem repeats could not be detected from the maternal plasma 24 h after delivery. Conclusion. Fluorescent PCR can be used for amplification of fetal SRY sequence and STRs in maternal plasma to obtain fetal genetic information, which may have implications for non-invasive prenatal diagnosis of certain hereditary diseases.

Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing

A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing.

The Fragmentation Patterns of Maternal Plasma Cell-Free DNA and Its Applications in Non-Invasive Prenatal Testing.

Effective Noninvasive Zygosity Determination By Maternal Plasma Target Region Sequencing

Level and different segments of free DNA molecules in maternal plasma

An Advanced Model To Precisely Estimate The Cell-Free Fetal Dna Concentration In Maternal Plasma

Noninvasive Detection of Fetal Subchromosomal Abnormalities by Semiconductor Sequencing of Maternal Plasma DNA

Detection of cell-free fetal DNA in maternal plasma using two types of compound markers.

Feasibility Study of Using Fetal DNA in Maternal Plasma for Non‐invasive Prenatal Diagnosis

DNA Methylome Profiling of Maternal Peripheral Blood and Placentas Reveal Potential Fetal DNA Markers for Non-Invasive Prenatal Testing.

Improving the accuracy of noninvasive prenatal testing through size-selection between fetal and maternal cfDNA

Size-selective separation and overall-amplification of cell-free fetal DNA fragments using PCR-based enrichment

Comprehensive Evaluation of the Impact of Whole-Genome Bisulfite Sequencing (WGBS) on the Fragmentomic Characteristics of Plasma Cell-Free DNA

Integrity of Cell-Free DNA in Maternal Plasma Extracellular Vesicles As a Potential Biomarker for Non-Invasive Prenatal Testing

Histone modifications of circulating nucleosomes are associated with changes in cell-free DNA fragmentation patterns

Detection of early-onset severe preeclampsia by cell-free DNA fragmentome

Single Molecule Sequencing of Cell-free DNA from Maternal Plasma for Noninvasive Trisomy Detection

Analysis of a Cell-Free DNA-based Cancer Screening Cohort Links Fragmentomic Profiles, Nuclease Levels, and Plasma DNA Concentrations

Noninvasive Prenatal Analysis by Multiplex Fluorescent Pcr of Maternal Plasma Dna

Detection of fetal trisomy and single gene disease by massively parallel sequencing of extracellular vesicle DNA in maternal plasma: a proof-of-concept validation

Integrative analyses of maternal plasma cell-free DNA nucleosome footprint differences reveal chromosomal aneuploidy fetuses gene expression profile